Kidney Tranplant Clinical Trial
— LER-Psy-PAKTOfficial title:
" Expérience Vécue, Représentations et Processus Psychiques Chez Les Sujets en Attente de Transplantation Rénale "
Verified date | October 2017 |
Source | University Hospital, Angers |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The kidney transplant remains the privileged treatment of the terminal renal insufficiency. This care is complex for the patient both on a medical surgical plan and by the psychic reorganizations. Among the temporary contraindications of transplantation, us retrouvonsdes psychological reasons. The research work consists in highlighting the psychic mechanisms of the subjects awaiting kidney transplant.
Status | Completed |
Enrollment | 33 |
Est. completion date | September 11, 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years old - stade 4 or 5 renal insufficiency - Registered on waiting list for a first kidney transplant Exclusion Criteria: - in ward - Unsigned consent - Already transplanted |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Angers |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measure of anxiety | STAI-Y questionnaire with 20 items used to measure anxiety degree | 6 months | |
Primary | Measure of psychic representations around transplant | ETA test: this test consists of an interview then the psychic projection through the drawing of 3 trees imagined by the patient and talking about him. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05913596 -
The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation
|
N/A |